Peritoneal Dialysis–Related Peritonitis with Acinetobacter Baumannii : A Review of Seven Cases
Author(s) -
Zhang Wei,
Wu Yong-Gui,
Qi Xiang-Ming,
Dai Hong,
Lu Wen,
Zhao Min
Publication year - 2014
Publication title -
peritoneal dialysis international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.79
H-Index - 83
eISSN - 1718-4304
pISSN - 0896-8608
DOI - 10.3747/pdi.2012.00198
Subject(s) - acinetobacter baumannii , peritonitis , peritoneal dialysis , medicine , continuous ambulatory peritoneal dialysis , intensive care medicine , acinetobacter , carbapenem , microbiology and biotechnology , antibiotics , pseudomonas aeruginosa , biology , bacteria , genetics
Peritonitis is still known as an important complication of continuous ambulatory peritoneal dialysis (CAPD). Multi-drug resistant (MDR) Acinetobacter baumannii is an increasing problem worldwide. Moreover, the increasing reports of carbapenem-resistant A. baumannii strains is common. Although peritoneal dialysis–related peritonitis with MDR A. baumannii is rarely reported, infection with this organism always results in serious peritonitis and increases the possibility of dropout or mortality. Here, we present 7 cases of peritonitis caused by A. baumannii species. Among those 7 cases, 2 involved MDR A. baumannii , and 1 involved a carbapenem-resistant strain. All the MDR bacterial infections failed treatment. We also review the literature about Acinetobacter peritonitis and current treatment protocols.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom